Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency

Molecular Genetics and Metabolism

Volumn 109, Issue 3, 2013, Pages 251-254

  Nagasaka, Hironori ^a   Yorifuji, Tohru ^b   Egawa, Hiroto ^c   Inui, Ayano ^d   Fujisawa, Tomoo ^d   Komatsu, Haruki ^d   Tsukahara, Hirokazu ^e   Uemoto, Shinji ^f   Inomata, Yukihiro ^g  

^a TAKARAZUKA CITY HOSPITAL   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f KYOTO UNIVERSITY HOSPITAL   (Japan)

^g KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Carriers; Nitric oxide citrulline cycle; Ornithine transcarbamylase deficiency; Urea cycle

Indexed keywords

AMMONIA; ARGININE; BENZOIC ACID; CITRULLINE; ENDOTHELIN 1; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE; ORNITHINE CARBAMOYLTRANSFERASE;

AMINO ACID BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; HEADACHE; HETEROZYGOTE; HUMAN; MALE; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; PRIORITY JOURNAL; SYNTHESIS; UREA CYCLE;

EID: 84891372955     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.04.013     Document Type: Article

References (13)

1. S.W. Brusilow, A.L. Horwich, Urea cycle enzymes, in: C.R. Schriver, A.L. Bauet, W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill, 2001, pp. 1909-1963.
2. S. Moncada, R.M.J. Palmer, E.A. Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43 (1991) 109-142.
3. H. Nagasaka, H. Komatsu, T. Ohura, T. Sogo, A. Inui, T. Yorifuji, H. Kikuta, K. Kobayashi, Nitric oxide synthesis in ornithine transcarbamylase deficiency: possible involvement of low NO synthesis in clinical manifestation of urea cycle defect, J. Pediatr. 145 (2004) 259-262.
4. H. Nagasaka, H. Tsukahara, T. Yorifuji, T. Miida, T. Takatani, M. Kanazawa, K. Kobayashi, Endogenous nitric oxide synthesis in congenital urea cycle enzyme defects, Metabolism 58 (2009) 278-282.
5. D.L. Pearson, S. Dawling, W.F. Walsh, J.L. Heines, B.W. Christman, A. Bazyk, N. Scott, M.L. Summar, Neonatal pulmonary hypertension urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function, N. Engl. J. Med. 344 (2001) 1832-1838.
6. J.P. Cook, ADMA: its role in vascular disease, Vasc. Med. 10 (2005) S11-S17.
7. H. Tsukahara, N. Ohta, S. Tokuriki, K. Nishijima, F. Kotsuji, H. Kawakami, N. Ohta, K. Sekine, H. Nagasaka, M. Mayumi, Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, umbilical blood, Metabolism 57 (2008) 215-220.
8. F. Shulze, R. Wesemann, E. Schwedhelm, Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay, Clin. Chem. Lab. Med. 42 (2004) 1377-1383.
9. G.M. Rubanyi, M.A. Polokoff, Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology, Pharmacol. Rev. 46 (1994) 325-415.
10. H. Nagasaka, Y. Okano, M. Aizawa, T. Miida, T. Yorifuji, G. Tajima, N. Sakura, T. Takatani, Y. Sanayama, K. Sugamoto, M. Mayumi, K. Kobayashi, K. Hirano, M. Takayanagi, H. Tsukahara, Altered metabolisms of mediators controlling vascular function and enhanced oxidative stress in asymptomatic children with congenital portosystemic venous shunt, Metabolism 59 (2010) 107-109.
11. S.W. Brusilow, E. Hauser, Simple method of measurement of orotate and orotidine in urine, J. Chromatogr. 493 (1989) 388-391.
12. S. Cupta, S.J. Nahas, B.L. Peterlin, Chemical mediators of migraine: preclinical and clinical observations, Headache 51 (2011) 1029-1045.
13. J. Olesen, Nitric oxide-related drug targets in headache, Neurotherapeutics 7 (2010) 183-190.